Profile: Prof. Alexander M.M. Eggermont, MD, PhD
Issue: Vol.7, No.2 - April 2008
Article Type: Profile
Prof. Alexander M.M.Eggermont, MD, PhD is a reputed Onco-surgeon is presently working as Professor and Head of Surgical Oncology at the Erasmus University Medical Center - Daniel den Hoed Cancer Center in Rotterdam, The Netherlands.
Prof. Eggermont, MD, PhD is Full Professor and Head of Surgical Oncology. He holds the Chair of Experimental Surgical Oncology endowed by the Dutch Cancer Society and the 'Joseph Maisin Chair' for Surgical Oncology at the Catholic University of Leuven in Belgium. In 1987 he obtained his PhD thesis on 'Interferon and IFN-Inducers in the Treatment of Cancer' at the Erasmus University Rotterdam. Dr. Eggermont is specialized in treatment of Melanoma, Soft Tissue Sarcoma, molecular staging methods, and isolated perfusion of extremities and organs. He holds a number of international positions: He is the immediate past President of the Organization for Research and Treatment of Cancer (EORTC) and previously served as Chairman of the EORTC Melanoma Group. He is the current President of ECCO (European Cancer Organization, formerly known as the Federation of European Cancer Societies (FECS)).
Also In This Issue
- Editorial: Bisphosphonate Associated Osteonecrosis
- How Sentinel Lymph Node Biopsy for Early Breast Cancer have Changed the Standard Care for the Patients in 2007: Review of Current Controversies
- Modulated Quality Assurance and Quality Control about Dose Intensity of Cervical Cancer Pelvic
- Application of Signal Transduction Inhibition as a Therapeutic Strategy for Adult T-Cell Leukemia
- Proof of Life: A Theoretical and Empirical Outline of a Community and Exercise-based Rehabilitation Initiative Developed by and for Young Adult Cancer Survivors
- Conformal Radiation Therapy for Patients with Unresectable Primary Liver Cancer: CRT is Now a Realistic Option
- The Priority of Risk-based Health Care for Australian Survivors of Childhood Cancer: Patient Self-reports of Concerns and the "Health Passport" Initiative
- Retrospective Analysis of Locally Advanced Gastric Cancer Patients from 2001- 2005 Treated with Combined Chemo-Radiation at Kuwait Cancer Center-INT-0116 Protocol
- Reactive Oxygen-Dependent DNA Damage Resulting from the Oxidation of Plumbagin by a Copper-redox Cycle Mechanism: Implications for its Anti-cancer Properties